Showing posts with label Tranzyme Pharma. Show all posts
Showing posts with label Tranzyme Pharma. Show all posts
Friday, February 8, 2013
Tranzyme Board to Explore Sale
Tranzyme Inc.'s board of directors will explore a possible sale, merger or business combination for the Durham drug developer, which recently ended research into its most advanced experimental treatment.
Thursday, December 6, 2012
Tranzyme Pharma’s CFO to Step Down
The vice president of finance and chief financial officer for the biopharmaceutical company Tranzyme Pharma, Richard Eisenstadt, announced Wednesday he has resigned effective Jan. 4.
Subscribe to:
Posts (Atom)